Hofseth BioCare ASA filed its Annual on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 NOK | -0.96% | -1.43% | -20.99% |
14/03 | Hofseth BioCare ASA Announces Board Changes | CI |
09/02 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-20.99% | 75.4M | |
-2.39% | 275B | |
-1.70% | 95.5B | |
-2.00% | 44.01B | |
+9.84% | 41.41B | |
+1.40% | 41.13B | |
+8.54% | 39.91B | |
-12.79% | 31.14B | |
-4.77% | 29.23B | |
+14.15% | 25.26B |
- Stock Market
- Equities
- HBC Stock
- News Hofseth BioCare ASA
- Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt